CytomX Therapeutics
CTMX
$1.89
Share price
-5.50%
Change (1 day)
6.78%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - P/B ratio
P/B ratio as of May 2024 : -3.28
According to CytomX Therapeutics
's latest financial reports the company has a price-to-book ratio of -3.28.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
CytomX Therapeutics - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -2.19 | 77.48% |
| 2022-12-31 | -1.23 | -99.8% |
| 2021-12-31 | -616 | 1414.05% |
| 2020-12-31 | -40.7 | -649.3% |
| 2019-12-31 | 7.40 | 42.3% |
| 2018-12-31 | 5.20 | -55.16% |
| 2017-12-31 | 11.6 | 127.56% |
| 2016-12-31 | 5.10 | -14.54% |
| 2015-12-31 | 5.97 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -182.63% | 🇺🇸 USA |